Evidence map›Paper›PMID 34221474›Full record

ArticleSultan Qaboos University medical journal2021

Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience.

Nihal Al-Riyami, Hanin Al-Badri, Sanjay Jaju, Silja Pillai

Open access · diamondAbstract read
In one paragraph

Article in Sultan Qaboos University medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Exploring death anxiety among women with preterm births in Oman.Journal of education and health promotion · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nihal Al-RiyamiDepartment of Obstetrics & Gynaecology, Sultan Qaboos University, Muscat, Oman.
Hanin Al-BadriCollege of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
Sanjay JajuDepartment of Family Medicine & Public Health, Sultan Qaboos University, Muscat, Oman.
Silja PillaiDepartment of Obstetrics & Gynaecology, Sultan Qaboos University Hospital, Muscat, Oman.
Sultan Qaboos University · OMSultan Qaboos University Hospital · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to generate baseline evidence regarding the effectiveness of atosiban in delaying delivery by ≥48 hours among pregnant women presenting with threatened preterm labour (TPL). The secondary objective was to assess the relationship between atosiban success and various perinatal factors and neonatal outcomes.

methodsThis retrospective study was conducted between June 2008 and May 2018 at the Sultan Qaboos University Hospital, Muscat, Oman. The medical records of all pregnant women who received atosiban between 24-34 gestational weeks for TPL during this period were reviewed.

resultsA total of 159 women were included in the study. Atosiban was successful in delaying delivery by ≥48 hours in 130 cases (81.8%). Approximately half of the women (50.9%) achieved uterine quiescence in <12 hours. Failure to delay delivery by ≥48 hours was significantly lower among women with normal versus abnormal cervical findings (11.1% versus 25.6%;

conclusionAtosiban was highly effective in delaying delivery by ≥48 hours and resulted in few adverse maternal side-effects and neonatal outcomes. To the best of the authors' knowledge, this is the first study conducted in Oman to evaluate the effectiveness of atosiban in preventing preterm labour.

Indexed as

FemaleHospitalsHumansInfant, NewbornObstetric Labor, PrematureOmanPatient Outcome AssessmentPregnancyRetrospective StudiesTocolytic AgentsTreatment OutcomeVasotocinatosibanTocolytic AgentsVasotocinAtosibanOmanPatient Outcome AssessmentPreterm LaborTocolytic AgentsTreatment Outcome

Identifiers

PMID34221474
PMCPMC8219335
OpenAlexW3176936319

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.